سعر سبيولتو ريسبيمات 2.5/2.5 ميكروجرام 60 بخه استنشاق 2022

Tiotropium 2.5 mcg + olodaterol 2.5 mcg per actuation inhalation spray (Respimat), 60 puffs; Boehringer Ingelheim.

• Long-term, once-daily maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Not for acute deterioration of COPD and not for asthma.Population: Adults with COPDDailyMed (U.S. National Library of Medicine)

• Most common (more than 3% and more than active control): nasopharyngitis, cough and back pain.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Use of a LABA without an inhaled corticosteroid in patients with asthma.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Hypersensitivity to tiotropium, ipratropium, olodaterol or any component.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Do not initiate in acutely deteriorating COPD and do not use for relief of acute symptoms (use a short-acting beta2-agonist).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Do not exceed the recommended dose or combine with other LABA-containing medicines (clinically significant, possibly fatal, cardiovascular effects).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Immediate hypersensitivity reactions and paradoxical bronchospasm: discontinue immediately.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Other adrenergic drugsMay potentiate sympathetic effects; use with caution.DailyMed (U.S. National Library of Medicine)
• Xanthine derivatives, steroids, non-potassium-sparing diureticsMay potentiate hypokalaemia or ECG changes; use with caution.DailyMed (U.S. National Library of Medicine)
• MAO inhibitors, tricyclic antidepressants, QTc-prolonging drugsMay potentiate cardiovascular effects; use with extreme caution.DailyMed (U.S. National Library of Medicine)

• No adequate studies in pregnant women; no structural abnormalities with inhaled tiotropium in rats and rabbits. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No data on presence in human milk; tiotropium, olodaterol and/or metabolites are present in rat milk. Weigh breastfeeding benefits against the mother's need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.